Published in Women's Health Weekly, July 10th, 1995
At issue are polyurethane foam-covered implants filled with silicone gel. Approximately 110,000 women have this type of implant.
In 1991, a chemical in the polyurethane was linked to cancer in laboratory animals. The FDA asked manufacturer Bristol-Myers Squibb to study the risk in women, and with that request, the company immediately stopped selling the implant.
The FDA announced June 29, 1995, that those studies show the risk of cancer from the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly